Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.06
CNMD's Cash-to-Debt is ranked lower than
95% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. CNMD: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
CNMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.06 Max: No Debt
Current: 0.06
Equity-to-Asset 0.44
CNMD's Equity-to-Asset is ranked lower than
74% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. CNMD: 0.44 )
Ranked among companies with meaningful Equity-to-Asset only.
CNMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.56 Max: 0.93
Current: 0.44
0.29
0.93
Interest Coverage 2.45
CNMD's Interest Coverage is ranked lower than
91% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. CNMD: 2.45 )
Ranked among companies with meaningful Interest Coverage only.
CNMD' s Interest Coverage Range Over the Past 10 Years
Min: 1.24  Med: 7.65 Max: 11.38
Current: 2.45
1.24
11.38
Piotroski F-Score: 5
Altman Z-Score: 2.38
Beneish M-Score: -2.51
WACC vs ROIC
4.44%
2.77%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 4.93
CNMD's Operating Margin % is ranked higher than
56% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. CNMD: 4.93 )
Ranked among companies with meaningful Operating Margin % only.
CNMD' s Operating Margin % Range Over the Past 10 Years
Min: 1.14  Med: 7.27 Max: 11.67
Current: 4.93
1.14
11.67
Net Margin % 1.92
CNMD's Net Margin % is ranked higher than
50% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. CNMD: 1.92 )
Ranked among companies with meaningful Net Margin % only.
CNMD' s Net Margin % Range Over the Past 10 Years
Min: 0.1  Med: 4.3 Max: 5.97
Current: 1.92
0.1
5.97
ROE % 2.52
CNMD's ROE % is ranked higher than
53% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. CNMD: 2.52 )
Ranked among companies with meaningful ROE % only.
CNMD' s ROE % Range Over the Past 10 Years
Min: 0.13  Med: 5.33 Max: 8.77
Current: 2.52
0.13
8.77
ROA % 1.14
CNMD's ROA % is ranked higher than
55% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. CNMD: 1.14 )
Ranked among companies with meaningful ROA % only.
CNMD' s ROA % Range Over the Past 10 Years
Min: 0.08  Med: 3.03 Max: 4.72
Current: 1.14
0.08
4.72
ROC (Joel Greenblatt) % 9.99
CNMD's ROC (Joel Greenblatt) % is ranked higher than
58% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. CNMD: 9.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CNMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.09  Med: 15.91 Max: 26.66
Current: 9.99
1.09
26.66
3-Year Revenue Growth Rate 0.20
CNMD's 3-Year Revenue Growth Rate is ranked lower than
67% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. CNMD: 0.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CNMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -1.2  Med: 7.5 Max: 40.8
Current: 0.2
-1.2
40.8
3-Year EBITDA Growth Rate -4.60
CNMD's 3-Year EBITDA Growth Rate is ranked lower than
66% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. CNMD: -4.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CNMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -44.5  Med: 9.5 Max: 139.6
Current: -4.6
-44.5
139.6
3-Year EPS without NRI Growth Rate -25.90
CNMD's 3-Year EPS without NRI Growth Rate is ranked lower than
80% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. CNMD: -25.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CNMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72  Med: 8.3 Max: 238.2
Current: -25.9
-72
238.2
GuruFocus has detected 5 Warning Signs with Conmed Corp $CNMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CNMD's 10-Y Financials

Financials (Next Earnings Date: 2017-07-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CNMD Guru Trades in Q2 2016

Steven Cohen 284,800 sh (New)
Ken Fisher 441,386 sh (+14.25%)
Mario Gabelli 88,800 sh (unchged)
Jim Simons 49,081 sh (-52.71%)
» More
Q3 2016

CNMD Guru Trades in Q3 2016

Ken Fisher 633,349 sh (+43.49%)
Mario Gabelli 88,800 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
» More
Q4 2016

CNMD Guru Trades in Q4 2016

Joel Greenblatt 11,606 sh (New)
Ken Fisher 632,386 sh (-0.15%)
Mario Gabelli 88,600 sh (-0.23%)
» More
Q1 2017

CNMD Guru Trades in Q1 2017

Ken Fisher 589,051 sh (-6.85%)
» More
» Details

Insider Trades

Latest Guru Trades with CNMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:MDXG, NAS:SPNC, NAS:BABY, NYSE:ITGR, NAS:CYNO, OTCPK:DGWPF, NAS:INGN, OTCPK:IOBCF, NAS:VASC, NAS:CSII, NAS:KTWO, OTCPK:NHNKY, OTCPK:MZRTF, NAS:OFIX, OTCPK:NMRD, NAS:GNMK, NYSE:CRY, NAS:XENT, NAS:ZLTQ, NYSE:IVC » details
Traded in other countries:EC8.Germany,
Headquarter Location:USA
Conmed Corp is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians.

Conmed Corp was incorporated under the laws of the State of New York in 1970. It is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Effective January 1, 2013, the Company is accounting and reporting business as a single segment entity engaged in the development, manufacturing and sale on a basis of surgical devices and related equipment. The business is derived from sales in orthopedic surgery product lines, including sports medicine, powered surgical instruments and sports biologics and tissue. These lines are marketed under a number of reputable brands, including Hall, CONMED Linvatec, Concept and Shutt. The surgical visualization product line offers endoscopic imaging and capture devices for the complete spectrum of surgical needs including 2DHD and 3DHD vision technologies. The general surgery product line offers in the areas ofenergy, endomechanical instrumentation, gastrointestinal, pulmonary and patient monitoring. The products are distributed domestically directly to more than 6,000 hospitals and other healthcare institutions as well as through medical specialty distributors and surgeons. The Company competes in orthopedic, surgical visualization and general surgery medical device markets across the world. The development, manufacture, sale and distribution of its products are subject to regulation by numerous agencies and legislative bodies, including the U.S. Food and Drug Administration (FDA) and comparable foreign counterparts.

Ratios

vs
industry
vs
history
PE Ratio 94.54
CNMD's PE Ratio is ranked lower than
85% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. CNMD: 94.54 )
Ranked among companies with meaningful PE Ratio only.
CNMD' s PE Ratio Range Over the Past 10 Years
Min: 9.85  Med: 35.37 Max: 3185
Current: 94.54
9.85
3185
Forward PE Ratio 26.67
CNMD's Forward PE Ratio is ranked lower than
56% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. CNMD: 26.67 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 94.54
CNMD's PE Ratio without NRI is ranked lower than
85% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. CNMD: 94.54 )
Ranked among companies with meaningful PE Ratio without NRI only.
CNMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.85  Med: 35.37 Max: 3185
Current: 94.54
9.85
3185
Price-to-Owner-Earnings 75.40
CNMD's Price-to-Owner-Earnings is ranked lower than
80% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. CNMD: 75.40 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CNMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.55  Med: 24.75 Max: 3333.33
Current: 75.4
8.55
3333.33
PB Ratio 2.36
CNMD's PB Ratio is ranked higher than
66% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. CNMD: 2.36 )
Ranked among companies with meaningful PB Ratio only.
CNMD' s PB Ratio Range Over the Past 10 Years
Min: 0.61  Med: 1.45 Max: 2.88
Current: 2.36
0.61
2.88
PS Ratio 1.80
CNMD's PS Ratio is ranked higher than
70% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. CNMD: 1.80 )
Ranked among companies with meaningful PS Ratio only.
CNMD' s PS Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.14 Max: 2.29
Current: 1.8
0.48
2.29
Price-to-Free-Cash-Flow 59.02
CNMD's Price-to-Free-Cash-Flow is ranked lower than
79% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. CNMD: 59.02 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CNMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.45  Med: 19.85 Max: 10230
Current: 59.02
7.45
10230
Price-to-Operating-Cash-Flow 36.07
CNMD's Price-to-Operating-Cash-Flow is ranked lower than
73% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. CNMD: 36.07 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CNMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.22  Med: 13.48 Max: 132.61
Current: 36.07
6.22
132.61
EV-to-EBIT 53.01
CNMD's EV-to-EBIT is ranked lower than
85% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. CNMD: 53.01 )
Ranked among companies with meaningful EV-to-EBIT only.
CNMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -200.6  Med: 24.2 Max: 226.5
Current: 53.01
-200.6
226.5
EV-to-EBITDA 20.45
CNMD's EV-to-EBITDA is ranked higher than
54% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. CNMD: 20.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
CNMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 13.1 Max: 43.1
Current: 20.45
5.5
43.1
PEG Ratio 9.36
CNMD's PEG Ratio is ranked lower than
80% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. CNMD: 9.36 )
Ranked among companies with meaningful PEG Ratio only.
CNMD' s PEG Ratio Range Over the Past 10 Years
Min: 1.44  Med: 6.31 Max: 1360.81
Current: 9.36
1.44
1360.81
Shiller PE Ratio 46.44
CNMD's Shiller PE Ratio is ranked higher than
58% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. CNMD: 46.44 )
Ranked among companies with meaningful Shiller PE Ratio only.
CNMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.35  Med: 28.82 Max: 65.24
Current: 46.44
10.35
65.24
Current Ratio 2.90
CNMD's Current Ratio is ranked higher than
59% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. CNMD: 2.90 )
Ranked among companies with meaningful Current Ratio only.
CNMD' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.34 Max: 13.53
Current: 2.9
1.37
13.53
Quick Ratio 1.71
CNMD's Quick Ratio is ranked lower than
52% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. CNMD: 1.71 )
Ranked among companies with meaningful Quick Ratio only.
CNMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.72 Max: 8.79
Current: 1.71
0.48
8.79
Days Inventory 169.10
CNMD's Days Inventory is ranked lower than
65% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. CNMD: 169.10 )
Ranked among companies with meaningful Days Inventory only.
CNMD' s Days Inventory Range Over the Past 10 Years
Min: 138.33  Med: 164.41 Max: 177.86
Current: 169.1
138.33
177.86
Days Sales Outstanding 70.87
CNMD's Days Sales Outstanding is ranked lower than
51% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. CNMD: 70.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
CNMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.39  Med: 66.74 Max: 74.33
Current: 70.87
42.39
74.33
Days Payable 42.80
CNMD's Days Payable is ranked lower than
66% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. CNMD: 42.80 )
Ranked among companies with meaningful Days Payable only.
CNMD' s Days Payable Range Over the Past 10 Years
Min: 22.06  Med: 27.69 Max: 42.8
Current: 42.8
22.06
42.8

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.63
CNMD's Dividend Yield % is ranked higher than
54% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.33 vs. CNMD: 1.63 )
Ranked among companies with meaningful Dividend Yield % only.
CNMD' s Dividend Yield % Range Over the Past 10 Years
Min: 0.5  Med: 1.78 Max: 2.22
Current: 1.63
0.5
2.22
Dividend Payout Ratio 1.82
CNMD's Dividend Payout Ratio is ranked lower than
93% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. CNMD: 1.82 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CNMD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.43  Med: 0.69 Max: 1.82
Current: 1.82
0.43
1.82
3-Year Dividend Growth Rate 7.20
CNMD's 3-Year Dividend Growth Rate is ranked lower than
53% of the 81 Companies
in the Global Medical Devices industry.

( Industry Median: 8.00 vs. CNMD: 7.20 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CNMD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 10.1
Current: 7.2
0
10.1
Forward Dividend Yield % 1.63
CNMD's Forward Dividend Yield % is ranked higher than
57% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. CNMD: 1.63 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.61
CNMD's 5-Year Yield-on-Cost % is ranked lower than
56% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. CNMD: 1.61 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CNMD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.5  Med: 1.78 Max: 2.22
Current: 1.61
0.5
2.22
3-Year Average Share Buyback Ratio -0.30
CNMD's 3-Year Average Share Buyback Ratio is ranked higher than
78% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. CNMD: -0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CNMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -18.8  Med: -0.7 Max: 1.3
Current: -0.3
-18.8
1.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.39
CNMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
82% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. CNMD: 1.39 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CNMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.77  Med: 1.19 Max: 3.5
Current: 1.39
0.77
3.5
Price-to-Intrinsic-Value-DCF (Earnings Based) 8.84
CNMD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
96% of the 25 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. CNMD: 8.84 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.58
CNMD's Price-to-Median-PS-Value is ranked lower than
76% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. CNMD: 1.58 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CNMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.59  Med: 1.04 Max: 2.89
Current: 1.58
0.59
2.89
Price-to-Peter-Lynch-Fair-Value 8.79
CNMD's Price-to-Peter-Lynch-Fair-Value is ranked lower than
95% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.61 vs. CNMD: 8.79 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CNMD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.55  Med: 1.78 Max: 135.11
Current: 8.79
0.55
135.11
Earnings Yield (Greenblatt) % 1.89
CNMD's Earnings Yield (Greenblatt) % is ranked lower than
51% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. CNMD: 1.89 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CNMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.4  Med: 4.1 Max: 12.7
Current: 1.89
0.4
12.7
Forward Rate of Return (Yacktman) % 14.38
CNMD's Forward Rate of Return (Yacktman) % is ranked higher than
65% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. CNMD: 14.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CNMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -13.3  Med: 6.65 Max: 18.8
Current: 14.38
-13.3
18.8

More Statistics

Revenue (TTM) (Mil) $763.5
EPS (TTM) $ 0.52
Beta0.43
Short Percentage of Float5.93%
52-Week Range $37.60 - 50.58
Shares Outstanding (Mil)27.87

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 772 803
EPS ($) 1.87 2.11
EPS without NRI ($) 1.87 2.11
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for CNMD

Headlines

Articles On GuruFocus.com
Jury Awards $10 Million In Punitive Damages Against SurgiQuest, A Subsidiary Of CONMED Corporation F Apr 13 2017 
Activist Hedge Fund Manager Jerome Lande Buys Stake in Technology Company Sep 25 2015 
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015 Financia Jan 14 2015 
CONMED Corporation to Announce Fourth Quarter 2014 Financial Results on January 27, 2015 Jan 08 2015 
CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference Dec 11 2014 
CONMED Corporation to Announce Third Quarter 2014 Financial Results on October 23, 2014 Oct 15 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Sells Highlight: Profire energy Inc, Graphic Packaging Holding Co, Seagate Technology PLC Aug 04 2014 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 

More From Other Websites
Edited Transcript of CNMD earnings conference call or presentation 26-Apr-17 8:30pm GMT Apr 28 2017
CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Apr 27 2017
Conmed reports 1Q loss Apr 26 2017
CONMED Corporation Announces First Quarter 2017 Financial Results Apr 26 2017
CONMED Corporation to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 19 2017
Jury Awards $10 Million In Punitive Damages Against SurgiQuest, A Subsidiary Of CONMED Corporation... Apr 13 2017
CONMED Corporation Announces Jury Verdict in Delaware Litigation Against SurgiQuest Apr 11 2017
CONMED Corporation to Announce First Quarter 2017 Financial Results on April 26, 2017 Apr 06 2017
CONMED Corp. : CNMD-US: Dividend Analysis : March 15th, 2017 (record date) : By the numbers : April... Apr 06 2017
CONMED Corp. breached its 50 day moving average in a Bearish Manner : CNMD-US : March 21, 2017 Mar 21 2017
CONMED Corporation Announces Annual Meeting of Shareholders Mar 07 2017
CONMED Corporation Announces Quarterly Cash Dividend Feb 28 2017
New Strong Sell Stocks for February 8th Feb 08 2017
CONMED Corp. :CNMD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017 Feb 07 2017
ETFs with exposure to CONMED Corp. : February 6, 2017 Feb 06 2017
CONMED Corp. :CNMD-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 Feb 02 2017
CONMED (CNMD) Q4 Earnings Miss Estimates, Increase Y/Y Feb 02 2017
Edited Transcript of CNMD earnings conference call or presentation 1-Feb-17 9:30pm GMT Feb 01 2017
Conmed misses Street 4Q forecasts Feb 01 2017
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2016 Financial Results Feb 01 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)